KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) Net Margin (2016 - 2025)

Biogen (BIIB) has 17 years of Net Margin data on record, last reported at 2.15% in Q4 2025.

  • For Q4 2025, Net Margin fell 1301.0% year-over-year to 2.15%; the TTM value through Dec 2025 reached 13.07%, down 380.0%, while the annual FY2025 figure was 13.07%, 380.0% down from the prior year.
  • Net Margin reached 2.15% in Q4 2025 per BIIB's latest filing, down from 18.4% in the prior quarter.
  • Across five years, Net Margin topped out at 45.59% in Q3 2022 and bottomed at 5.42% in Q3 2023.
  • Average Net Margin over 5 years is 15.3%, with a median of 16.79% recorded in 2021.
  • Peak YoY movement for Net Margin: surged 5044bps in 2022, then tumbled -5101bps in 2023.
  • A 5-year view of Net Margin shows it stood at 3.72% in 2021, then surged by 690bps to 21.97% in 2022, then plummeted by -125bps to 5.42% in 2023, then surged by 301bps to 10.86% in 2024, then crashed by -120bps to 2.15% in 2025.
  • Per Business Quant database, its latest 3 readings for Net Margin were 2.15% in Q4 2025, 18.4% in Q3 2025, and 24.0% in Q2 2025.